Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus
Allison August, Husain Attarwala, Sunny Himansu, et al.
Nature Medicine (2021) Vol. 27, Iss. 12, pp. 2224-2233
Open Access | Times Cited: 112

Showing 26-50 of 112 citing articles:

Development of Vaccines against Emerging Mosquito-Vectored Arbovirus Infections
Nicola Principi, Susanna Esposito
Vaccines (2024) Vol. 12, Iss. 1, pp. 87-87
Open Access | Times Cited: 9
mRNA Technology in Modern Medicine: Review and Future Prospects
Heslley Machado Silva
Deleted Journal (2025) Vol. 2, pp. 1-1
Closed Access | Times Cited: 1
In vivo production of engineered ACE2 decoy protects lungs from SARS-CoV-2 infection
Yuta Suzuki, Takayuki Miyazaki, Yoko Ida, et al.
Molecular Therapy — Nucleic Acids (2025) Vol. 36, Iss. 1, pp. 102467-102467
Open Access | Times Cited: 1
Liposomes and liposome-like nanoparticles: From anti-fungal infection to the COVID-19 pandemic treatment
Yonglong He, Wanting Zhang, Qingqing Xiao, et al.
Asian Journal of Pharmaceutical Sciences (2022) Vol. 17, Iss. 6, pp. 817-837
Open Access | Times Cited: 37
Lipid Nanoparticle Delivery System for mRNA Encoding B7H3‐redirected Bispecific Antibody Displays Potent Antitumor Effects on Malignant Tumors
Cheng Huang, Xing Duan, Jichao Wang, et al.
Advanced Science (2022) Vol. 10, Iss. 3
Open Access | Times Cited: 34
Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants
William R. Strohl, Zhiqiang Ku, Zhiqiang An, et al.
BioDrugs (2022) Vol. 36, Iss. 3, pp. 231-323
Open Access | Times Cited: 32
A phase 1, randomized, placebo-controlled, dose-ranging study to evaluate the safety and immunogenicity of an mRNA-based chikungunya virus vaccine in healthy adults
Christine A. Shaw, Allison August, Stephan Bart, et al.
Vaccine (2023) Vol. 41, Iss. 26, pp. 3898-3906
Closed Access | Times Cited: 22
The research progress of Chikungunya fever
Li Cai, Xinyi Hu, Shuang Liu, et al.
Frontiers in Public Health (2023) Vol. 10
Open Access | Times Cited: 17
A generalized framework to identify SARS-CoV-2 broadly neutralizing antibodies
Fanchong Jian, Anna Z. Wec, Leilei Feng, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 8
Extracellular vesicles versus lipid nanoparticles for the delivery of nucleic acids
Johannes Bader, Finn Brigger, Jean‐Christophe Leroux
Advanced Drug Delivery Reviews (2024), pp. 115461-115461
Open Access | Times Cited: 7
Pathogenicity and virulence of chikungunya virus
Wesley Freppel, Laurie A. Silva, Kenneth A. Stapleford, et al.
Virulence (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Comprehensive analysis of lipid nanoparticle formulation and preparation for RNA delivery
Md. Anamul Haque, Archana Shrestha, Constantinos M. Mikelis, et al.
International Journal of Pharmaceutics X (2024) Vol. 8, pp. 100283-100283
Open Access | Times Cited: 6
Development of intravenously administered synthetic RNA virus immunotherapy for the treatment of cancer
Edward M. Kennedy, Agnieszka Denslow, Jacqueline Hewett, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 26
A Review: The Antiviral Activity of Cyclic Peptides
Le Yi Chia, Palanirajan Vijayaraj Kumar, Marwan Abdelmahmoud Abdelkarim Maki, et al.
International Journal of Peptide Research and Therapeutics (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 24
Recent Progress in the Discovery and Development of Monoclonal Antibodies against Viral Infections
Pardis Mokhtary, Zeinab Pourhashem, Akram Abouei Mehrizi, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1861-1861
Open Access | Times Cited: 23
Chikungunya Virus: Priority Pathogen or Passing Trend?
Gerardo Montalvo Zurbia-Flores, Arturo Reyes‐Sandoval, Young Chan Kim
Vaccines (2023) Vol. 11, Iss. 3, pp. 568-568
Open Access | Times Cited: 16
Mechanisms and research advances in mRNA antibody drug-mediated passive immunotherapy
Yuxiang Zhao, Linchuan Gan, Dangjin Ke, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 16
Expanding the Reach of Monoclonal Antibodies: A Review of Synthetic Nucleic Acid Delivery in Immunotherapy
Christopher Chung, Sagar B. Kudchodkar, Curtis N. Chung, et al.
Antibodies (2023) Vol. 12, Iss. 3, pp. 46-46
Open Access | Times Cited: 15
Broadly neutralizing antibodies targeting HIV: Progress and challenges
Paneerselvam Nandagopal, Amber Khan, Brian R. Lawson
Clinical Immunology (2023) Vol. 257, pp. 109809-109809
Closed Access | Times Cited: 13
Monoclonal antibody applications in travel medicine
Hanna K. de Jong, Martin P. Grobusch
Tropical Diseases Travel Medicine and Vaccines (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 6
Chikungunya Vaccine Candidates: Current Landscape and Future Prospects
Christin Schmidt, Barbara S. Schnierle
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 3663-3673
Open Access | Times Cited: 21
Nebulized mRNA‐Encoded Antibodies Protect Hamsters from SARS‐CoV‐2 Infection
Daryll Vanover, Chiara Zurla, Hannah E. Peck, et al.
Advanced Science (2022) Vol. 9, Iss. 34
Open Access | Times Cited: 21
RNA nanotechnology: A new chapter in targeted therapy
Tongtong Lv, Yingying Meng, Yifan Liu, et al.
Colloids and Surfaces B Biointerfaces (2023) Vol. 230, pp. 113533-113533
Closed Access | Times Cited: 12
An mRNA-based platform for the delivery of pathogen-specific IgA into mucosal secretions
Cailin E. Deal, Angelene F. Richards, Tracy Yeung, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 11, pp. 101253-101253
Open Access | Times Cited: 12
Differences and Similarities of the Intravenously Administered Lipid Nanoparticles in Three Clinical Trials: Potential Linkage between Lipid Nanoparticles and Extracellular Vesicles
Yuta Suzuki, Yuri Katsurada, Kenji Hyodo
Molecular Pharmaceutics (2023) Vol. 20, Iss. 10, pp. 4883-4892
Closed Access | Times Cited: 11

Scroll to top